Skip to Main Content
Search this site:
Tell us your thoughts
Share Your Content
Do you have or know about content you would like to see added to this website?
Submit your content
In the Blink of an Eye
A Patient's View of Dry-Eye Disease
The Pros and Cons of Dry-Eye Technologies
Mucins: Foundation of A Good Tear Film
Glaucoma and Dry Eye: A Tough Combo
The Promising Next Wave Of Dry-Eye Products
Dry Eye Summit Leaders
Mark B. Abelson
Founder, Chairman, and CSO Ora, Inc.
George . Ousler
Vice President, Dry Eye Ora, Inc.
Which current drugs in the Dry Eye development pipeline have the greatest chance for success?
Is there a Mechanism of Action that stands out from the rest?
Mechanism of Action
Dry Eye development
© 2011, Dry Eye Summit.